BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 2193673)

  • 1. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men.
    Margalith M; Sarov B; Sarov I; Rinaldo C; Detels R; Phair J; Kaslow R; Ginsberg H; Saah A
    AIDS Res Hum Retroviruses; 1990 May; 6(5):607-16. PubMed ID: 2193673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus IgG and IgA serum antibodies in a study of HIV infection and HIV related diseases in homosexual men.
    Levy E; Margalith M; Sarov B; Sarov I; Rinaldo CR; Detels R; Phair J; Kaslow R; Ginzburg H; Saah AJ
    J Med Virol; 1991 Nov; 35(3):174-9. PubMed ID: 1666647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
    Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
    J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced antibody responses to Epstein-Barr virus in HIV-infected homosexual men.
    Rahman MA; Kingsley LA; Breinig MK; Ho M; Armstrong JA; Atchison RW; Lyter DW; Rinaldo CR
    J Infect Dis; 1989 Mar; 159(3):472-9. PubMed ID: 2536790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening.
    Fachiroh J; Paramita DK; Hariwiyanto B; Harijadi A; Dahlia HL; Indrasari SR; Kusumo H; Zeng YS; Schouten T; Mubarika S; Middeldorp JM
    J Clin Microbiol; 2006 Apr; 44(4):1459-67. PubMed ID: 16597877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
    Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
    J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chlamydia specific IgG and IgA serum antibodies in a study of homosexual men at various clinical stages of HIV related disease.
    Sarov B; Saah AJ; Levy E; Elsana S; Sarov I; Rinaldo CR; Detels R; Phair J; Kaslow R; Gisnberg H
    In Vivo; 1994; 8(4):593-7. PubMed ID: 7893987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral antibodies in the sera of homosexual men: correlation with their lifestyle and drug usage.
    Nerurkar LS; Biggar RJ; Goedert JJ; Wallen W; Becker P; West F; Tzan N; Traub R; Lee YJ; Botelar W
    J Med Virol; 1987 Feb; 21(2):123-35. PubMed ID: 3029318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [IgA antibodies against Epstein-Barr virus capsid antigen].
    Chalupa P; Slesinger P; Krchnáková A; Prásek J
    Cas Lek Cesk; 1992 Sep; 131(17):526-9. PubMed ID: 1330312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of HTLV-III with Epstein-Barr virus infection and abnormalities of T lymphocytes in homosexual men.
    Rinaldo CR; Kingsley LA; Lyter DW; Rabin BS; Atchison RW; Bodner AJ; Weiss SH; Saxinger WC
    J Infect Dis; 1986 Oct; 154(4):556-61. PubMed ID: 3018092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implication of pretreatment titer of serum immunoglobulin A against Epstein-Barr virus capsid antigen in nasopharyngeal carcinoma patients in Sihui, Guangdong.
    Ling W; Cao SM; Huang QH; Li YH; Deng MQ
    Ai Zheng; 2009 Jan; 28(1):57-9. PubMed ID: 19448418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of serum IgM IgA and IgG antibodies specific for Epstein-Barr virus as determined by immunoperoxidase assay in the rapid diagnosis of infectious mononucleosis.
    Hadar T; Margalith M; Sagiv E; Sarov B; Sarov I
    Isr J Med Sci; 1995 May; 31(5):280-3. PubMed ID: 7759222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reliability of IgA antibody to Epstein-Barr virus (EBV) capsid antigen as a test for the diagnosis of nasopharyngeal carcinoma (NPC).
    Levine PH; Pearson GR; Armstrong M; Bengali Z; Berenberg J; Easton J; Goepfert H; Henle G; Henle W; Heffner D; Huang A; Hyams VJ; Lanier A; Neel HB; Pilch B; Pointek N; Taylor W; Terebelo H; Weiland L
    Cancer Detect Prev; 1981; 4(1-4):307-12. PubMed ID: 6299561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
    Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
    Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.